View Future GrowthLB Group 과거 순이익 실적과거 기준 점검 1/6LB Group의 수입은 연평균 -18.6%의 비율로 감소해 온 반면, Chemicals 산업은 수입이 연평균 5.6% 감소했습니다. 매출은 연평균 7.9%의 비율로 증가해 왔습니다. LB Group의 자기자본이익률은 2.6%이고 순이익률은 2.9%입니다.핵심 정보-18.65%순이익 성장률-20.98%주당순이익(EPS) 성장률Chemicals 산업 성장률12.10%매출 성장률7.88%자기자본이익률2.55%순이익률2.86%최근 순이익 업데이트31 Mar 2026최근 과거 실적 업데이트공시 • Mar 31LB Group Co., Ltd. to Report Q1, 2026 Results on Apr 28, 2026LB Group Co., Ltd. announced that they will report Q1, 2026 results on Apr 28, 2026공시 • Dec 31LB Group Co., Ltd. to Report Fiscal Year 2025 Results on Apr 28, 2026LB Group Co., Ltd. announced that they will report fiscal year 2025 results on Apr 28, 2026공시 • Sep 30LB Group Co., Ltd. to Report Q3, 2025 Results on Oct 28, 2025LB Group Co., Ltd. announced that they will report Q3, 2025 results on Oct 28, 2025공시 • Jul 02LB Group Co., Ltd. to Report First Half, 2025 Results on Aug 26, 2025LB Group Co., Ltd. announced that they will report first half, 2025 results on Aug 26, 2025공시 • Mar 31LB Group Co., Ltd. to Report Q1, 2025 Results on Apr 24, 2025LB Group Co., Ltd. announced that they will report Q1, 2025 results on Apr 24, 2025공시 • Dec 31LB Group Co., Ltd. to Report Fiscal Year 2024 Results on Apr 24, 2025LB Group Co., Ltd. announced that they will report fiscal year 2024 results on Apr 24, 2025모든 업데이트 보기Recent updatesBoard Change • May 20Less than half of directors are independentFollowing the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Director Hongwei Li was the last independent director to join the board, commencing their role in 2026. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.공시 • Apr 28LB Group Co., Ltd., Annual General Meeting, May 18, 2026LB Group Co., Ltd., Annual General Meeting, May 18, 2026, at 14:30 China Standard Time. Location: The Company's Meeting Room, Jiaozuo, Hebei China공시 • Mar 31LB Group Co., Ltd. to Report Q1, 2026 Results on Apr 28, 2026LB Group Co., Ltd. announced that they will report Q1, 2026 results on Apr 28, 2026공시 • Dec 31LB Group Co., Ltd. to Report Fiscal Year 2025 Results on Apr 28, 2026LB Group Co., Ltd. announced that they will report fiscal year 2025 results on Apr 28, 2026공시 • Oct 29LB Group Co., Ltd. Proposes Cash Dividend (Tax Included) for Third Quarter 2025LB Group Co., Ltd. at the Extraordinary General Meeting of 2025 held on 12 November 2025, proposed cash dividend (tax included) for third quarter 2025 of CNY 1.00000000 per 10 shares.공시 • Sep 30LB Group Co., Ltd. to Report Q3, 2025 Results on Oct 28, 2025LB Group Co., Ltd. announced that they will report Q3, 2025 results on Oct 28, 2025공시 • Jul 02LB Group Co., Ltd. to Report First Half, 2025 Results on Aug 26, 2025LB Group Co., Ltd. announced that they will report first half, 2025 results on Aug 26, 2025공시 • Jun 06LB Group Co., Ltd. Announces First Quarter Distribution, Payable on June 11, 2025LB Group Co., Ltd. announced that the 2025 1st quarter profit distribution plan to be implemented (A shares): Cash dividend/10 shares (tax included): CNY 5.00. Record date: 10 June 2025. Ex-date: 11 June 2025. Payment date: 11 June 2025.공시 • Apr 25LB Group Co., Ltd. Proposes Cash Dividend for the First Quarter 2025LB Group Co., Ltd. proposed first quarter 2025 cash dividend of CNY 5.00000000 per 10 shares (tax included).공시 • Apr 24LB Group Co., Ltd., Annual General Meeting, May 14, 2025LB Group Co., Ltd., Annual General Meeting, May 14, 2025, at 14:30 China Standard Time. Location: The Company's Meeting Room, Jiaozuo, Henan China공시 • Mar 31LB Group Co., Ltd. to Report Q1, 2025 Results on Apr 24, 2025LB Group Co., Ltd. announced that they will report Q1, 2025 results on Apr 24, 2025공시 • Dec 31LB Group Co., Ltd. to Report Fiscal Year 2024 Results on Apr 24, 2025LB Group Co., Ltd. announced that they will report fiscal year 2024 results on Apr 24, 2025공시 • Nov 15LB Group Co., Ltd. Approves 3rd Quarter Profit Distribution Plan for 2024LB Group Co., Ltd. held its 2nd Extraordinary General Meeting of 2024 on 13 November 2024, during were approved 2024 3rd quarter profit distribution plan as Cash dividend/10 shares (tax included): CNY 3.00000000.공시 • Oct 30LB Group Co., Ltd. Proposes Cash Dividend for the Third Quarter of 2024LB Group Co., Ltd. announced profit distribution proposal for the third quarter of 2024. For the quarter, the company reported Cash dividend/10 shares (tax included) is CNY 3.00000000.Reported Earnings • Oct 29Third quarter 2024 earnings released: EPS: CN¥0.36 (vs CN¥0.37 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.36 (down from CN¥0.37 in 3Q 2023). Revenue: CN¥7.09b (up 1.1% from 3Q 2023). Net income: CN¥842.2m (down 4.3% from 3Q 2023). Profit margin: 12% (in line with 3Q 2023). Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings.공시 • Sep 30LB Group Co., Ltd. to Report Q3, 2024 Results on Oct 29, 2024LB Group Co., Ltd. announced that they will report Q3, 2024 results on Oct 29, 2024Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥19.38, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 21% over the past three years.Reported Earnings • Aug 28Second quarter 2024 earnings released: EPS: CN¥0.31 (vs CN¥0.29 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.31 (up from CN¥0.29 in 2Q 2023). Revenue: CN¥6.52b (up 3.8% from 2Q 2023). Net income: CN¥770.4m (up 13% from 2Q 2023). Profit margin: 12% (in line with 2Q 2023). Revenue is forecast to grow 9.6% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has fallen by 24% per year, which means it is performing significantly worse than earnings.공시 • Jun 29LB Group Co., Ltd. to Report First Half, 2024 Results on Aug 28, 2024LB Group Co., Ltd. announced that they will report first half, 2024 results on Aug 28, 2024공시 • Jun 18LB Group Co., Ltd. (SZSE:002601) announces an Equity Buyback for CNY 200 million worth of its shares.LB Group Co., Ltd. (SZSE:002601) announces a share repurchase program. Under the program, the company will repurchase up to CNY 200 million worth of its shares. The shares will be purchased at a price not exceeding CNY 32.10 per share. The purpose of the program is to further establish and improve the company's long-term incentive mechanism, attract and retain outstanding talents, safeguard the legitimate rights and interests of all shareholders of the company, and promote the stable and healthy development of the company. The repurchased shares will be used for employee stock ownership plans or equity incentive plans, otherwise will be cancelled if the company fails to transfer them within the time limit stipulated by relevant laws and regulations. The program will be funded from company's own funds. The program will be valid for 12 months.Declared Dividend • May 27Dividend of CN¥0.60 announcedDividend of CN¥0.60 is the same as last year. Ex-date: 30th May 2024 Payment date: 30th May 2024 Dividend yield will be 4.1%, which is higher than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (19% earnings payout ratio) but not covered by cash flows (177% cash payout ratio). The dividend has increased by an average of 51% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 53% over the next 3 years, which should provide support to the dividend and adequate earnings cover.공시 • May 25Lb Group Co., Ltd. Approves the Cash Dividend of A Shares for the First Quarter of 2024, Payable on 30 May 2024LB Group Co., Ltd. approved the cash dividend of CNY 6.00000000 per 10 A shares (tax included) for the first quarter of 2024. Record date is 29 May 2024. Ex-date is 30 May 2024. Payment date is 30 May 2024.공시 • Apr 24LB Group Co., Ltd., Annual General Meeting, May 14, 2024LB Group Co., Ltd., Annual General Meeting, May 14, 2024, at 14:30 China Standard Time. Location: The Company's Meeting Room, Jiaozuo, Henan ChinaReported Earnings • Apr 24First quarter 2024 earnings released: EPS: CN¥0.41 (vs CN¥0.24 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.41 (up from CN¥0.24 in 1Q 2023). Revenue: CN¥7.29b (up 4.6% from 1Q 2023). Net income: CN¥951.1m (up 64% from 1Q 2023). Profit margin: 13% (up from 8.3% in 1Q 2023). Revenue is forecast to grow 18% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 13% per year whereas the company’s share price has fallen by 18% per year.공시 • Mar 30LB Group Co., Ltd. to Report Q1, 2024 Results on Apr 24, 2024LB Group Co., Ltd. announced that they will report Q1, 2024 results on Apr 24, 2024공시 • Dec 30LB Group Co., Ltd. to Report Fiscal Year 2023 Results on Apr 24, 2024LB Group Co., Ltd. announced that they will report fiscal year 2023 results on Apr 24, 2024공시 • Nov 02LB Group Co., Ltd. Implements 3rd Quarter Profit Distribution Plan for 2023, payable on 08 November 2023LB Group Co., Ltd. announced 2023 3rd quarter profit distribution plan to be implemented (A shares) Cash dividend/10 shares (tax included): CNY 3.00000000. Record date: 07 November 2023, Ex-date: 08 November 2023, Payment date: 08 November 2023.공시 • Nov 01LB Group Co., Ltd. Approves Cash Dividend for the Third Quarter of 2023LB Group Co., Ltd. in its 7th Extraordinary General Meeting of 2023 on 30 October 2023 approved the cash dividend per 10 shares (tax included) of CNY 3.00000000 for the third quarter of 2023.공시 • Oct 17LB Group Co., Ltd. Proposes Quarterly Cash Dividend for the Third Quarter of 2023LB Group Co., Ltd. proposed quarterly cash dividend per 10 shares (tax included) of CNY 3.00000000 for the third quarter of 2023.Reported Earnings • Oct 14Third quarter 2023 earnings released: EPS: CN¥0.37 (vs CN¥0.40 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.37 (down from CN¥0.40 in 3Q 2022). Revenue: CN¥7.04b (up 25% from 3Q 2022). Net income: CN¥880.0m (down 3.0% from 3Q 2022). Profit margin: 13% (down from 16% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has fallen by 11% per year, which means it is performing significantly worse than earnings.Reported Earnings • Aug 26Second quarter 2023 earnings released: EPS: CN¥0.29 (vs CN¥0.57 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.29 (down from CN¥0.57 in 2Q 2022). Revenue: CN¥6.29b (flat on 2Q 2022). Net income: CN¥682.6m (down 43% from 2Q 2022). Profit margin: 11% (down from 19% in 2Q 2022). Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.공시 • May 24LB Group Co., Ltd. Approves Cash Dividend on A Shares for the First Quarter of 2023, Payable on May 29, 2023LB Group Co., Ltd. approved Cash dividend/10 shares (tax included) of CNY 6.00000000 on A shares for the first quarter of 2023, payable on May 29, 2023. Record date: May 26, 2023; and Ex-date: May 29, 2023.Reported Earnings • Apr 29First quarter 2023 earnings released: EPS: CN¥0.24 (vs CN¥0.45 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.24 (down from CN¥0.45 in 1Q 2022). Revenue: CN¥6.98b (up 15% from 1Q 2022). Net income: CN¥579.4m (down 46% from 1Q 2022). Profit margin: 8.3% (down from 18% in 1Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 21% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.Board Change • Nov 16High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. CFO, Financial Manager & Non-Independent Director Qing Fei Shen was the last director to join the board, commencing their role in 2020. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Oct 25Third quarter 2022 earnings released: EPS: CN¥0.40 (vs CN¥0.76 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.40 (down from CN¥0.76 in 3Q 2021). Revenue: CN¥5.66b (up 4.3% from 3Q 2021). Net income: CN¥907.0m (down 35% from 3Q 2021). Profit margin: 16% (down from 26% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 19% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.Buying Opportunity • Sep 17Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 20%. The fair value is estimated to be CN¥20.83, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 29% over the last 3 years. Earnings per share has grown by 22%. Revenue is forecast to grow by 42% in 2 years. Earnings is forecast to grow by 32% in the next 2 years.Reported Earnings • Aug 24Second quarter 2022 earnings released: EPS: CN¥0.57 (vs CN¥0.60 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.57 (down from CN¥0.60 in 2Q 2021). Revenue: CN¥6.36b (up 22% from 2Q 2021). Net income: CN¥1.20b (down 12% from 2Q 2021). Profit margin: 19% (down from 26% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 23%, compared to a 42% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth.Board Change • May 27High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. CFO, Financial Manager & Non-Independent Director Qing Fei Shen was the last director to join the board, commencing their role in 2020. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Apr 14Full year 2021 earnings releasedFull year 2021 results: Net income: CN¥4.68b (up 104% from FY 2020).Reported Earnings • Oct 26Third quarter 2021 earnings released: EPS CN¥0.76 (vs CN¥0.32 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥5.47b (up 53% from 3Q 2020). Net income: CN¥1.40b (up 113% from 3Q 2020). Profit margin: 26% (up from 18% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 32% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Sep 28Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to CN¥28.24, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 148% over the past three years.Reported Earnings • Aug 24Second quarter 2021 earnings released: EPS CN¥0.60 (vs CN¥0.20 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥5.22b (up 98% from 2Q 2020). Net income: CN¥1.37b (up 250% from 2Q 2020). Profit margin: 26% (up from 15% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has increased by 34% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Aug 14Investor sentiment improved over the past weekAfter last week's 21% share price gain to CN¥36.42, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 228% over the past three years.Valuation Update With 7 Day Price Move • Jul 05Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to CN¥30.61, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 199% over the past three years.Reported Earnings • Apr 17Full year 2020 earnings released: EPS CN¥1.13 (vs CN¥1.29 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: CN¥14.2b (up 25% from FY 2019). Net income: CN¥2.29b (down 12% from FY 2019). Profit margin: 16% (down from 23% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has increased by 16% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Mar 25Investor sentiment deteriorated over the past weekAfter last week's 21% share price decline to CN¥27.26, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 22x in the Chemicals industry in China. Total returns to shareholders of 79% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥13.54 per share.Valuation Update With 7 Day Price Move • Mar 10Investor sentiment deteriorated over the past weekAfter last week's 23% share price decline to CN¥32.00, the stock is trading at a trailing P/E ratio of 26.4x, down from the previous P/E ratio of 34.4x. This compares to an average P/E of 35x in the Chemicals industry in China. Total returns to shareholders over the past three years are 107%.Valuation Update With 7 Day Price Move • Feb 12Investor sentiment improved over the past weekAfter last week's 19% share price gain to CN¥48.48, the stock is trading at a trailing P/E ratio of 40x, up from the previous P/E ratio of 33.5x. This compares to an average P/E of 35x in the Chemicals industry in China. Total returns to shareholders over the past three years are 236%.Is New 90 Day High Low • Feb 11New 90-day high: CN¥48.48The company is up 61% from its price of CN¥30.06 on 13 November 2020. The Chinese market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 21% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥13.71 per share.Is New 90 Day High Low • Jan 21New 90-day high: CN¥41.43The company is up 67% from its price of CN¥24.76 on 23 October 2020. The Chinese market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 19% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥13.66 per share.Valuation Update With 7 Day Price Move • Jan 06Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥35.72, the stock is trading at a trailing P/E ratio of 29.5x, up from the previous P/E ratio of 25.4x. This compares to an average P/E of 36x in the Chemicals industry in China. Total returns to shareholders over the past three years are 149%.Is New 90 Day High Low • Jan 05New 90-day high: CN¥35.12The company is up 51% from its price of CN¥23.29 on 30 September 2020. The Chinese market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 16% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥13.79 per share.Valuation Update With 7 Day Price Move • Nov 13Market bids up stock over the past weekAfter last week's 16% share price gain to CN¥30.06, the stock is trading at a trailing P/E ratio of 24.8x, up from the previous P/E ratio of 21.4x. This compares to an average P/E of 39x in the Chemicals industry in China. Total returns to shareholders over the past three years are 141%.Valuation Update With 7 Day Price Move • Nov 11Market bids up stock over the past weekAfter last week's 17% share price gain to CN¥29.30, the stock is trading at a trailing P/E ratio of 24.2x, up from the previous P/E ratio of 20.6x. This compares to an average P/E of 39x in the Chemicals industry in China. Total returns to shareholders over the past three years are 126%.Is New 90 Day High Low • Nov 11New 90-day high: CN¥29.30The company is up 26% from its price of CN¥23.25 on 13 August 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥11.72 per share.Reported Earnings • Nov 03Third quarter 2020 earnings released: EPS CN¥0.32The company reported a soft third quarter result with weaker earnings and profit margins, although revenues were improved. Third quarter 2020 results: Revenue: CN¥3.61b (up 24% from 3Q 2019). Net income: CN¥656.8m (down 18% from 3Q 2019). Profit margin: 18% (down from 27% in 3Q 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 15% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Oct 13Market bids up stock over the past weekAfter last week's 21% share price gain to CN¥28.25, the stock is trading at a trailing P/E ratio of 21.9x, up from the previous P/E ratio of 18.1x. This compares to an average P/E of 40x in the Chemicals industry in China. Total returns to shareholders over the past three years are 92%.Is New 90 Day High Low • Oct 12New 90-day high: CN¥26.61The company is up 12% from its price of CN¥23.83 on 14 July 2020. The Chinese market is down 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥10.92 per share.매출 및 비용 세부 내역LB Group가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이XSEC:002601 매출, 비용 및 순이익 (CNY Millions)날짜매출순이익일반관리비연구개발비31 Mar 2626,0697451,7341,09031 Dec 2525,9691,2451,7241,13430 Sep 2526,0831,2791,4161,14630 Jun 2527,0521,8321,4861,16331 Mar 2527,2791,9041,4391,21531 Dec 2427,5132,1691,5181,17530 Sep 2427,3703,6481,56478330 Jun 2427,3093,6861,55878931 Mar 2427,0803,5981,66691831 Dec 2326,7653,2261,5831,01430 Sep 2326,3452,2631,8551,14530 Jun 2324,9612,2901,8051,17731 Mar 2325,0182,8091,8211,06801 Jan 2324,1133,2941,8661,01430 Sep 2223,3274,0191,8501,26330 Jun 2223,1284,5081,8821,24631 Mar 2221,9894,6771,8401,16501 Jan 2220,5664,6761,6191,01030 Sep 2119,4804,1701,07482630 Jun 2117,6233,43192566431 Mar 2115,0662,45184253031 Dec 2014,1122,28996453930 Sep 2012,9892,4781,20449130 Jun 2012,3262,6171,19945731 Mar 2012,2742,8721,16942531 Dec 1911,3622,5941,04441630 Sep 1910,6912,3811,08446530 Jun 1910,5462,2151,08746831 Mar 1910,6742,3111,08444831 Dec 1810,4442,2861,05839930 Sep 1810,7312,55294144530 Jun 1810,5592,53378659931 Mar 1810,4562,51592749531 Dec 1710,2582,50295241930 Sep 179,6572,24397927030 Jun 177,7971,681981031 Mar 175,8571,011681031 Dec 164,136442561030 Sep 162,767172322030 Jun 162,612136297031 Mar 162,644114298031 Dec 152,635111295030 Sep 152,37096282030 Jun 152,324982890양질의 수익: 002601는 고품질 수익을 보유하고 있습니다.이익 마진 증가: 002601의 현재 순 이익률 (2.9%)은 지난해 (7%)보다 낮습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: 002601의 수익은 지난 5년 동안 연평균 18.6% 감소했습니다.성장 가속화: 002601은 지난 1년 동안 수익이 감소하여 5년 평균과 비교할 수 없습니다.수익 대 산업: 002601은 지난 1년 동안 수익이 감소(-60.8%)하여 Chemicals 업계 평균(3.7%)과 비교하기 어렵습니다.자기자본이익률높은 ROE: 002601의 자본 수익률(2.6%)은 낮음으로 평가됩니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMaterials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/23 22:41종가2026/05/22 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스LB Group Co., Ltd.는 16명의 분석가가 다루고 있습니다. 이 중 9명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Xiongwei JiaChina International Capital Corporation LimitedZhe WangCitic Securities Co., Ltd.Oscar YeeCitigroup Inc13명의 분석가 더 보기
공시 • Mar 31LB Group Co., Ltd. to Report Q1, 2026 Results on Apr 28, 2026LB Group Co., Ltd. announced that they will report Q1, 2026 results on Apr 28, 2026
공시 • Dec 31LB Group Co., Ltd. to Report Fiscal Year 2025 Results on Apr 28, 2026LB Group Co., Ltd. announced that they will report fiscal year 2025 results on Apr 28, 2026
공시 • Sep 30LB Group Co., Ltd. to Report Q3, 2025 Results on Oct 28, 2025LB Group Co., Ltd. announced that they will report Q3, 2025 results on Oct 28, 2025
공시 • Jul 02LB Group Co., Ltd. to Report First Half, 2025 Results on Aug 26, 2025LB Group Co., Ltd. announced that they will report first half, 2025 results on Aug 26, 2025
공시 • Mar 31LB Group Co., Ltd. to Report Q1, 2025 Results on Apr 24, 2025LB Group Co., Ltd. announced that they will report Q1, 2025 results on Apr 24, 2025
공시 • Dec 31LB Group Co., Ltd. to Report Fiscal Year 2024 Results on Apr 24, 2025LB Group Co., Ltd. announced that they will report fiscal year 2024 results on Apr 24, 2025
Board Change • May 20Less than half of directors are independentFollowing the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Director Hongwei Li was the last independent director to join the board, commencing their role in 2026. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
공시 • Apr 28LB Group Co., Ltd., Annual General Meeting, May 18, 2026LB Group Co., Ltd., Annual General Meeting, May 18, 2026, at 14:30 China Standard Time. Location: The Company's Meeting Room, Jiaozuo, Hebei China
공시 • Mar 31LB Group Co., Ltd. to Report Q1, 2026 Results on Apr 28, 2026LB Group Co., Ltd. announced that they will report Q1, 2026 results on Apr 28, 2026
공시 • Dec 31LB Group Co., Ltd. to Report Fiscal Year 2025 Results on Apr 28, 2026LB Group Co., Ltd. announced that they will report fiscal year 2025 results on Apr 28, 2026
공시 • Oct 29LB Group Co., Ltd. Proposes Cash Dividend (Tax Included) for Third Quarter 2025LB Group Co., Ltd. at the Extraordinary General Meeting of 2025 held on 12 November 2025, proposed cash dividend (tax included) for third quarter 2025 of CNY 1.00000000 per 10 shares.
공시 • Sep 30LB Group Co., Ltd. to Report Q3, 2025 Results on Oct 28, 2025LB Group Co., Ltd. announced that they will report Q3, 2025 results on Oct 28, 2025
공시 • Jul 02LB Group Co., Ltd. to Report First Half, 2025 Results on Aug 26, 2025LB Group Co., Ltd. announced that they will report first half, 2025 results on Aug 26, 2025
공시 • Jun 06LB Group Co., Ltd. Announces First Quarter Distribution, Payable on June 11, 2025LB Group Co., Ltd. announced that the 2025 1st quarter profit distribution plan to be implemented (A shares): Cash dividend/10 shares (tax included): CNY 5.00. Record date: 10 June 2025. Ex-date: 11 June 2025. Payment date: 11 June 2025.
공시 • Apr 25LB Group Co., Ltd. Proposes Cash Dividend for the First Quarter 2025LB Group Co., Ltd. proposed first quarter 2025 cash dividend of CNY 5.00000000 per 10 shares (tax included).
공시 • Apr 24LB Group Co., Ltd., Annual General Meeting, May 14, 2025LB Group Co., Ltd., Annual General Meeting, May 14, 2025, at 14:30 China Standard Time. Location: The Company's Meeting Room, Jiaozuo, Henan China
공시 • Mar 31LB Group Co., Ltd. to Report Q1, 2025 Results on Apr 24, 2025LB Group Co., Ltd. announced that they will report Q1, 2025 results on Apr 24, 2025
공시 • Dec 31LB Group Co., Ltd. to Report Fiscal Year 2024 Results on Apr 24, 2025LB Group Co., Ltd. announced that they will report fiscal year 2024 results on Apr 24, 2025
공시 • Nov 15LB Group Co., Ltd. Approves 3rd Quarter Profit Distribution Plan for 2024LB Group Co., Ltd. held its 2nd Extraordinary General Meeting of 2024 on 13 November 2024, during were approved 2024 3rd quarter profit distribution plan as Cash dividend/10 shares (tax included): CNY 3.00000000.
공시 • Oct 30LB Group Co., Ltd. Proposes Cash Dividend for the Third Quarter of 2024LB Group Co., Ltd. announced profit distribution proposal for the third quarter of 2024. For the quarter, the company reported Cash dividend/10 shares (tax included) is CNY 3.00000000.
Reported Earnings • Oct 29Third quarter 2024 earnings released: EPS: CN¥0.36 (vs CN¥0.37 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.36 (down from CN¥0.37 in 3Q 2023). Revenue: CN¥7.09b (up 1.1% from 3Q 2023). Net income: CN¥842.2m (down 4.3% from 3Q 2023). Profit margin: 12% (in line with 3Q 2023). Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings.
공시 • Sep 30LB Group Co., Ltd. to Report Q3, 2024 Results on Oct 29, 2024LB Group Co., Ltd. announced that they will report Q3, 2024 results on Oct 29, 2024
Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥19.38, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 21% over the past three years.
Reported Earnings • Aug 28Second quarter 2024 earnings released: EPS: CN¥0.31 (vs CN¥0.29 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.31 (up from CN¥0.29 in 2Q 2023). Revenue: CN¥6.52b (up 3.8% from 2Q 2023). Net income: CN¥770.4m (up 13% from 2Q 2023). Profit margin: 12% (in line with 2Q 2023). Revenue is forecast to grow 9.6% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has fallen by 24% per year, which means it is performing significantly worse than earnings.
공시 • Jun 29LB Group Co., Ltd. to Report First Half, 2024 Results on Aug 28, 2024LB Group Co., Ltd. announced that they will report first half, 2024 results on Aug 28, 2024
공시 • Jun 18LB Group Co., Ltd. (SZSE:002601) announces an Equity Buyback for CNY 200 million worth of its shares.LB Group Co., Ltd. (SZSE:002601) announces a share repurchase program. Under the program, the company will repurchase up to CNY 200 million worth of its shares. The shares will be purchased at a price not exceeding CNY 32.10 per share. The purpose of the program is to further establish and improve the company's long-term incentive mechanism, attract and retain outstanding talents, safeguard the legitimate rights and interests of all shareholders of the company, and promote the stable and healthy development of the company. The repurchased shares will be used for employee stock ownership plans or equity incentive plans, otherwise will be cancelled if the company fails to transfer them within the time limit stipulated by relevant laws and regulations. The program will be funded from company's own funds. The program will be valid for 12 months.
Declared Dividend • May 27Dividend of CN¥0.60 announcedDividend of CN¥0.60 is the same as last year. Ex-date: 30th May 2024 Payment date: 30th May 2024 Dividend yield will be 4.1%, which is higher than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (19% earnings payout ratio) but not covered by cash flows (177% cash payout ratio). The dividend has increased by an average of 51% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 53% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
공시 • May 25Lb Group Co., Ltd. Approves the Cash Dividend of A Shares for the First Quarter of 2024, Payable on 30 May 2024LB Group Co., Ltd. approved the cash dividend of CNY 6.00000000 per 10 A shares (tax included) for the first quarter of 2024. Record date is 29 May 2024. Ex-date is 30 May 2024. Payment date is 30 May 2024.
공시 • Apr 24LB Group Co., Ltd., Annual General Meeting, May 14, 2024LB Group Co., Ltd., Annual General Meeting, May 14, 2024, at 14:30 China Standard Time. Location: The Company's Meeting Room, Jiaozuo, Henan China
Reported Earnings • Apr 24First quarter 2024 earnings released: EPS: CN¥0.41 (vs CN¥0.24 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.41 (up from CN¥0.24 in 1Q 2023). Revenue: CN¥7.29b (up 4.6% from 1Q 2023). Net income: CN¥951.1m (up 64% from 1Q 2023). Profit margin: 13% (up from 8.3% in 1Q 2023). Revenue is forecast to grow 18% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 13% per year whereas the company’s share price has fallen by 18% per year.
공시 • Mar 30LB Group Co., Ltd. to Report Q1, 2024 Results on Apr 24, 2024LB Group Co., Ltd. announced that they will report Q1, 2024 results on Apr 24, 2024
공시 • Dec 30LB Group Co., Ltd. to Report Fiscal Year 2023 Results on Apr 24, 2024LB Group Co., Ltd. announced that they will report fiscal year 2023 results on Apr 24, 2024
공시 • Nov 02LB Group Co., Ltd. Implements 3rd Quarter Profit Distribution Plan for 2023, payable on 08 November 2023LB Group Co., Ltd. announced 2023 3rd quarter profit distribution plan to be implemented (A shares) Cash dividend/10 shares (tax included): CNY 3.00000000. Record date: 07 November 2023, Ex-date: 08 November 2023, Payment date: 08 November 2023.
공시 • Nov 01LB Group Co., Ltd. Approves Cash Dividend for the Third Quarter of 2023LB Group Co., Ltd. in its 7th Extraordinary General Meeting of 2023 on 30 October 2023 approved the cash dividend per 10 shares (tax included) of CNY 3.00000000 for the third quarter of 2023.
공시 • Oct 17LB Group Co., Ltd. Proposes Quarterly Cash Dividend for the Third Quarter of 2023LB Group Co., Ltd. proposed quarterly cash dividend per 10 shares (tax included) of CNY 3.00000000 for the third quarter of 2023.
Reported Earnings • Oct 14Third quarter 2023 earnings released: EPS: CN¥0.37 (vs CN¥0.40 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.37 (down from CN¥0.40 in 3Q 2022). Revenue: CN¥7.04b (up 25% from 3Q 2022). Net income: CN¥880.0m (down 3.0% from 3Q 2022). Profit margin: 13% (down from 16% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has fallen by 11% per year, which means it is performing significantly worse than earnings.
Reported Earnings • Aug 26Second quarter 2023 earnings released: EPS: CN¥0.29 (vs CN¥0.57 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.29 (down from CN¥0.57 in 2Q 2022). Revenue: CN¥6.29b (flat on 2Q 2022). Net income: CN¥682.6m (down 43% from 2Q 2022). Profit margin: 11% (down from 19% in 2Q 2022). Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.
공시 • May 24LB Group Co., Ltd. Approves Cash Dividend on A Shares for the First Quarter of 2023, Payable on May 29, 2023LB Group Co., Ltd. approved Cash dividend/10 shares (tax included) of CNY 6.00000000 on A shares for the first quarter of 2023, payable on May 29, 2023. Record date: May 26, 2023; and Ex-date: May 29, 2023.
Reported Earnings • Apr 29First quarter 2023 earnings released: EPS: CN¥0.24 (vs CN¥0.45 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.24 (down from CN¥0.45 in 1Q 2022). Revenue: CN¥6.98b (up 15% from 1Q 2022). Net income: CN¥579.4m (down 46% from 1Q 2022). Profit margin: 8.3% (down from 18% in 1Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 21% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.
Board Change • Nov 16High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. CFO, Financial Manager & Non-Independent Director Qing Fei Shen was the last director to join the board, commencing their role in 2020. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Oct 25Third quarter 2022 earnings released: EPS: CN¥0.40 (vs CN¥0.76 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.40 (down from CN¥0.76 in 3Q 2021). Revenue: CN¥5.66b (up 4.3% from 3Q 2021). Net income: CN¥907.0m (down 35% from 3Q 2021). Profit margin: 16% (down from 26% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 19% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.
Buying Opportunity • Sep 17Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 20%. The fair value is estimated to be CN¥20.83, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 29% over the last 3 years. Earnings per share has grown by 22%. Revenue is forecast to grow by 42% in 2 years. Earnings is forecast to grow by 32% in the next 2 years.
Reported Earnings • Aug 24Second quarter 2022 earnings released: EPS: CN¥0.57 (vs CN¥0.60 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.57 (down from CN¥0.60 in 2Q 2021). Revenue: CN¥6.36b (up 22% from 2Q 2021). Net income: CN¥1.20b (down 12% from 2Q 2021). Profit margin: 19% (down from 26% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 23%, compared to a 42% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth.
Board Change • May 27High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. CFO, Financial Manager & Non-Independent Director Qing Fei Shen was the last director to join the board, commencing their role in 2020. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Apr 14Full year 2021 earnings releasedFull year 2021 results: Net income: CN¥4.68b (up 104% from FY 2020).
Reported Earnings • Oct 26Third quarter 2021 earnings released: EPS CN¥0.76 (vs CN¥0.32 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥5.47b (up 53% from 3Q 2020). Net income: CN¥1.40b (up 113% from 3Q 2020). Profit margin: 26% (up from 18% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 32% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Sep 28Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to CN¥28.24, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 148% over the past three years.
Reported Earnings • Aug 24Second quarter 2021 earnings released: EPS CN¥0.60 (vs CN¥0.20 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥5.22b (up 98% from 2Q 2020). Net income: CN¥1.37b (up 250% from 2Q 2020). Profit margin: 26% (up from 15% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has increased by 34% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Aug 14Investor sentiment improved over the past weekAfter last week's 21% share price gain to CN¥36.42, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 228% over the past three years.
Valuation Update With 7 Day Price Move • Jul 05Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to CN¥30.61, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 199% over the past three years.
Reported Earnings • Apr 17Full year 2020 earnings released: EPS CN¥1.13 (vs CN¥1.29 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: CN¥14.2b (up 25% from FY 2019). Net income: CN¥2.29b (down 12% from FY 2019). Profit margin: 16% (down from 23% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has increased by 16% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Mar 25Investor sentiment deteriorated over the past weekAfter last week's 21% share price decline to CN¥27.26, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 22x in the Chemicals industry in China. Total returns to shareholders of 79% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥13.54 per share.
Valuation Update With 7 Day Price Move • Mar 10Investor sentiment deteriorated over the past weekAfter last week's 23% share price decline to CN¥32.00, the stock is trading at a trailing P/E ratio of 26.4x, down from the previous P/E ratio of 34.4x. This compares to an average P/E of 35x in the Chemicals industry in China. Total returns to shareholders over the past three years are 107%.
Valuation Update With 7 Day Price Move • Feb 12Investor sentiment improved over the past weekAfter last week's 19% share price gain to CN¥48.48, the stock is trading at a trailing P/E ratio of 40x, up from the previous P/E ratio of 33.5x. This compares to an average P/E of 35x in the Chemicals industry in China. Total returns to shareholders over the past three years are 236%.
Is New 90 Day High Low • Feb 11New 90-day high: CN¥48.48The company is up 61% from its price of CN¥30.06 on 13 November 2020. The Chinese market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 21% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥13.71 per share.
Is New 90 Day High Low • Jan 21New 90-day high: CN¥41.43The company is up 67% from its price of CN¥24.76 on 23 October 2020. The Chinese market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 19% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥13.66 per share.
Valuation Update With 7 Day Price Move • Jan 06Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥35.72, the stock is trading at a trailing P/E ratio of 29.5x, up from the previous P/E ratio of 25.4x. This compares to an average P/E of 36x in the Chemicals industry in China. Total returns to shareholders over the past three years are 149%.
Is New 90 Day High Low • Jan 05New 90-day high: CN¥35.12The company is up 51% from its price of CN¥23.29 on 30 September 2020. The Chinese market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 16% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥13.79 per share.
Valuation Update With 7 Day Price Move • Nov 13Market bids up stock over the past weekAfter last week's 16% share price gain to CN¥30.06, the stock is trading at a trailing P/E ratio of 24.8x, up from the previous P/E ratio of 21.4x. This compares to an average P/E of 39x in the Chemicals industry in China. Total returns to shareholders over the past three years are 141%.
Valuation Update With 7 Day Price Move • Nov 11Market bids up stock over the past weekAfter last week's 17% share price gain to CN¥29.30, the stock is trading at a trailing P/E ratio of 24.2x, up from the previous P/E ratio of 20.6x. This compares to an average P/E of 39x in the Chemicals industry in China. Total returns to shareholders over the past three years are 126%.
Is New 90 Day High Low • Nov 11New 90-day high: CN¥29.30The company is up 26% from its price of CN¥23.25 on 13 August 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥11.72 per share.
Reported Earnings • Nov 03Third quarter 2020 earnings released: EPS CN¥0.32The company reported a soft third quarter result with weaker earnings and profit margins, although revenues were improved. Third quarter 2020 results: Revenue: CN¥3.61b (up 24% from 3Q 2019). Net income: CN¥656.8m (down 18% from 3Q 2019). Profit margin: 18% (down from 27% in 3Q 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 15% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Oct 13Market bids up stock over the past weekAfter last week's 21% share price gain to CN¥28.25, the stock is trading at a trailing P/E ratio of 21.9x, up from the previous P/E ratio of 18.1x. This compares to an average P/E of 40x in the Chemicals industry in China. Total returns to shareholders over the past three years are 92%.
Is New 90 Day High Low • Oct 12New 90-day high: CN¥26.61The company is up 12% from its price of CN¥23.83 on 14 July 2020. The Chinese market is down 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥10.92 per share.